By May, pharmacies will no longer be able to dispense compounded versions, though that depends on ongoing litigation
Microdosing represents an alternative approach that some providers use during transitions
Nausea affects approximately 32% of patients, but this typically occurs early in treatment and resolves within weeks
A patient with significant constipation, reflux, a history of gallbladder issues, diabetes medication interactions, dehydration risk, or inadequate protein intake may need a different strategy than a patient whose main concern is appetite control
Once-daily oral semaglutide Semaglutide is available as an oral tablet under the brand name Rybelsus to help people with type-2 diabetes achieve adequate glycemic control
For more information, contact us or book an appointment